292 results on '"United States"'
Search Results
2. Women and smoking: a report of the Surgeon General: executive summary.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
3. Outbreak of measles -- Venezuela and Colombia, 2001-2002.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
4. Unrecognized HIV infection, risk behaviors, and perceptions of risk among young black men who have sex with men -- six U.S. cities, 1994-1998.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
5. Nonfatal sports- and recreation-related injuries treated in emergency departments -- United States, July 2000-June 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
6. Barriers to children walking and biking to school -- United States, 1999.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
7. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC.
- Author
-
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Group B streptococcus (GBS) remains a leading cause of serious neonatal infection despite great progress in perinatal GBS disease prevention in the 1990s. In 1996, CDC, in collaboration with other agencies, published guidelines for the prevention of perinatal group B streptococcal disease (CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45[RR-7]:1--24). Data collected after the issuance of the 1996 guidelines prompted reevaluation of prevention strategies at a meeting of clinical and public health representatives in November 2001. This report replaces CDC's 1996 guidelines. The recommendations are based on available evidence and expert opinion where sufficient evidence was lacking. Although many of the recommendations in the 2002 guidelines are the same as those in 1996, they include some key changes:* Recommendation of universal prenatal screening for vaginal and rectal GBS colonization of all pregnant women at 35--37 weeks' gestation, based on recent documentation in a large retrospective cohort study of a strong protective effect of this culture-based screening strategy relative to the risk-based strategy* Updated prophylaxis regimens for women with penicillin allergy* Detailed instruction on prenatal specimen collection and expanded methods of GBS culture processing, including instructions on antimicrobial susceptibility testing* Recommendation against routine intrapartum antibiotic prophylaxis for GBS-colonized women undergoing planned cesarean deliveries who have not begun labor or had rupture of membranes* A suggested algorithm for management of patients with threatened preterm delivery* An updated algorithm for management of newborns exposed to intrapartum antibiotic prophylaxisAlthough universal screening for GBS colonization is anticipated to result in further reductions in the burden of GBS disease, the need to monitor for potential adverse consequences of intrapartum antibiotic use, such as emergence of bacterial antimicrobial resistance or increased incidence or severity of non-GBS neonatal pathogens, continues, and intrapartum antibiotics are still viewed as an interim strategy until GBS vaccines achieve licensure. [ABSTRACT FROM AUTHOR]
- Published
- 2002
8. Guidelines for the prevention of intravascular catheter-related infections.
- Author
-
O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masure H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
These guidelines have been developed for practitioners who insert catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home health-care settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, health-care infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Disease Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), Society of Cardiovascular and Interventional Radiology (SCVIR), American Academy of Pediatrics (AAP), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Device-Related Infections published in 1996. These guidelines are intended to provide evidence-based recommendations for preventing catheter-related infections. Major areas of emphasis include 1) educating and training health-care providers who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a 2% chlorhexidine preparation for skin antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies (i.e., education and training, maximal sterile barrier precautions, and 2% chlorhexidine for skin antisepsis). These guidelines also identify performance indicators that can be used locally by health-care institutions or organizations to monitor their success in implementing these evidence-based recommendations. [ABSTRACT FROM AUTHOR]
- Published
- 2002
9. Chronic obstructive pulmonary disease surveillance -- United States, 1971-2000.
- Author
-
Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
bProblem/Condition: Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis and emphysema but has been defined recently as the physiologic finding of nonreversible pulmonary function impairment. This surveillance summary reports trends in different measures of COPD during 1971--2000.Reporting Period Covered: This report presents national data regarding objectively determined COPD (1971--1994); COPD-associated activity and functional limitations (1980--1996); self-reported COPD prevalence, COPD physician office and hospital outpatient department visits, COPD hospitalizations, and COPD deaths (1980--2000); and COPD emergency department visits (1992--2000).Description of Systems: CDC's National Center for Health Statistics (NCHS) conducts the National Health Interview Survey annually, which includes questions concerning COPD and activity limitations. NCHS collects physician office-visit data in the National Ambulatory Medical Care Survey, emergency department and hospital outpatient department data in the National Hospital Ambulatory Medical Care Survey, hospitalization data in the National Hospital Discharge Survey, and death data in the Mortality Component of the National Vital Statistics System. Data regarding pulmonary function were obtained from the National Health and Nutrition Examination Surveys (NHANES) I (1971--1975) and III (1988--1994), and data regarding functional limitation were obtained from NHANES III, Phase 2 (1991--1994).Results: During 2000, an estimated 10 million U.S. adults reported physician-diagnosed COPD. However, data from NHANES III estimate that approximately 24 million U.S. adults have evidence of impaired lung function, indicating that COPD is underdiagnosed. During 2000, COPD was responsible for 8 million physician office and hospital outpatient visits, 1.5 million emergency department visits, 726,000 hospitalizations, and 119,000 deaths. During the period analyzed, the most substantial change was the increase in the COPD death rate for women, from 20.1/100,000 in 1980 to 56.7/100,000 in 2000, compared with the more modest increase in the death rate for men, from 73.0/100,000 in 1980 to 82.6/100,000 in 2000. In 2000, for the first time, the number of women dying from COPD surpassed the number of men dying from COPD (59,936 versus 59,118). Another substantial change observed is that the proportion of the population aged <55 years with mild or moderate COPD, on the basis of pulmonary function testing, decreased from 1971--1975 to 1988--1994, possibly indicating that the upward trends in COPD hospitalizations and mortality might not continue.Interpretation: COPD is a major cause of morbidity, mortality, and disability in the United States. Despite its ease of diagnosis, COPD remains an underdiagnosed disease, chiefly in its milder and more treatable form. [ABSTRACT FROM AUTHOR]
- Published
- 2002
10. Cigarette smoking among adults -- United States, 2000.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
11. Methemoglobinemia following unintentional ingestion of sodium nitrite -- New York, 2002.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
12. Hantavirus pulmonary syndrome -- United States: updated recommendations for risk reduction.
- Author
-
Mills JN, Corneli A, Young JC, Garrison LE, Khan AS, Ksiazek TG, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
This report provides updated recommendations for prevention and control of hantavirus infections associated with rodents in the United States. It supersedes the previous report (CDC. Hantavirus infection -- southwestern United States: interim recommendations for risk reduction. MMWR 1993;42[No. RR-11]:1--13). These recommendations are based on principles of rodent and infection control, and accumulating evidence that most infections result from exposure, in closed spaces, to active infestations of infected rodents. The recommendations contain updated specific measures and precautions for limiting household, recreational, and occupational exposure to rodents, eliminating rodent infestations, rodent-proofing human dwellings, cleaning up rodent-contaminated areas and dead rodents, and working in homes of persons with confirmed hantavirus infection or buildings with heavy rodent infestations. [ABSTRACT FROM AUTHOR]
- Published
- 2002
13. Hepatitis B vaccination among high-risk adolescents and adults -- San Diego, California, 1998-2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
14. Infant mortality and low birth weight among black and white infants -- United States, 1980-2000.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
15. Update: AIDS -- United States, 2000.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
16. Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance -- United States, 1994-2000.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
17. Hysterectomy surveillance -- United States, 1994-1999.
- Author
-
Keshavarz H, Hillis SD, Kieke BA, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: Hysterectomy is the second most frequently performed surgical procedure, after cesarean section, for women of reproductive age in the United States. Approximately 600,000 hysterectomies are performed annually in the United States, and approximately 20 million U.S. women have had a hysterectomy.Reporting Period Covered: This report covers data from 1994 through 1999Description of System: Estimates of the population of U.S. female, civilian residents were used to compute rates for this study. Population denominators were obtained from the U.S. Bureau of the Census. The National Hospital Discharge Survey (NHDS) was the data source for this report. NHDS is conducted by CDC's National Center for Health Statistics. NHDS is an annual, multistage probability sample of short-stay patients (those hospitalized <30 days) discharged from nonfederal hospitals in the United States.Results and Interpretation: From 1994 through 1999, an estimated 3,525,237 hysterectomies were performed among U.S. women aged >/=15 years, and the overall hysterectomy rate for U.S. female, civilian residents was 5.5 per 1,000 women. Although statistically significant increases for hysterectomy rates were observed from 1994 (5.1/1,000) through 1998 (5.8/1,000), the increase was limited and the curve remained nearly flat.Women aged 40--44 years had a significantly higher hysterectomy rate compared with any other age group. During the study period, 52% of all hysterectomies were performed among women aged =44 years. In addition, hysterectomy rates per 1,000 in women aged 45--54 years increased significantly, from 8.9 in 1994 to 10 in 1999. The overall hysterectomy rate for women living in the South was 6.5 per 1,000, which was significantly higher than the rate among women who lived in either the Northeast (4.3) or the West (4.8) but not significantly higher than the rate among women who lived in the Midwest (5.4). Uterine leiomyoma, endometriosis, and uterine prolapse were the most frequent diagnoses for women aged >/=15 years. The percentage of uterine leiomyoma as a primary diagnosis for hysterectomy increased 10.2% for white women, 7.8% for black women, and 23% for women of other races. Among women who had a hysterectomy during the study period, 55% also had a bilateral oophorectomy. The proportion of all vaginal hysterectomies with concomitant laparoscopy (LAVH) increased significantly, from 13% in 1994 to 28% in 1999. During this same period, the percentage of cases of LAVH with concomitant bilateral oophorectomy increased significantly, from 20.4% in 1994 to 42.5% in 1999.Public Health Actions: Continued monitoring of hysterectomy trends will be necessary to evaluate differences in hysterectomy rates by age, most commonly associated diagnoses, whether leiomyomata as a primary discharge diagnosis continues to increase, and whether the increase in LAVH that occurred during the previous decade continues. [ABSTRACT FROM AUTHOR]
- Published
- 2002
18. Malaria surveillance -- United States, 2001.
- Author
-
Causer LM, Newman RD, Barber AM, Roberts JM, Stennies G, Bloland PB, Parise ME, Steketee RW, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: Malaria is caused by four species of intraerythrocytic protozoa of the genus Plasmodium (i.e., P. falciparum, P. vivax, P. ovale, or P. malariae). Malaria is transmitted by the bite of an infective female Anopheles sp. mosquito. The majority of malaria infections in the United States occur among persons who have traveled to areas with ongoing transmission. In the United States, cases can occur through exposure to infected blood products, by congenital transmission, or locally through mosquitoborne transmission. Malaria surveillance is conducted to identify episodes of local transmission and to guide prevention recommendations for travelers.Period Covered: Cases with onset of illness during 2000.Description of System: Malaria cases confirmed by blood smear are reported to local and state health departments by health-care providers or laboratory staff. Case investigations are conducted by local and state health departments, and reports are transmitted to CDC through the National Malaria Surveillance System (NMSS). Data from NMSS serve as the basis for this report.Results: CDC received reports of 1,402 cases of malaria with an onset of symptoms during 2000 among persons in the United States or one of its territories. This number represents a decrease of 9.0% from the 1,540 cases reported for 1999. P. falciparum, P. vivax, P. malariae, and P. ovale were identified in 43.6%, 37.2%, 4.8%, and 2.3% of cases, respectively. Nine patients (0.6% of total) were infected by >/=2 species. The infecting species was unreported or undetermined in 161 (11.5%) cases. Compared with 1999, the number of reported malaria cases acquired in Africa decreased by 13.1% (n = 783), and a decrease of 3.3% (n = 238) occurred in cases acquired in Asia. Cases from the Americas decreased by 1.1% (n = 271) from 1999. Of 825 U.S. civilians who acquired malaria abroad, 190 (23.0%) reported that they had followed a chemoprophylactic drug regimen recommended by CDC for the area to which they had traveled. Four patients became infected in the United States, two through congenital transmission and two through probable induced transmission. Six deaths were attributed to malaria, four caused by P. falciparum, one caused by P. malariae, and one by P. ovale.Interpretation: The 9.0% decrease in malaria cases in 2000, compared with 1999, resulted primarily from decreases in cases acquired in Africa and Asia. This decrease could have resulted from local changes in disease transmission, decreased travel to these regions, fluctuation in reporting to state and local health departments, or an increased use of effective antimalarial chemoprophylaxis. In the majority of reported cases, U.S. civilians who acquired infection abroad were not on an appropriate chemoprophylaxis regimen for the country in which they acquired malaria.Public Health Actions: Additional information was obtained concerning the six fatal cases and the four infections acquired in the United States. Persons traveling to a malarious area should take one of the recommended chemoprophylaxis regimens appropriate for the region of travel, and travelers should use personal protection measures to prevent mosquito bites. Any person who has been to a malarious area and who subsequently develops a fever or influenza-like symptoms should seek medical care immediately and report their travel history to the clinician; investigation should include a blood-film test for malaria. Malaria infections can be fatal if not diagnosed and treated promptly. Recommendations concerning malaria prevention can be obtained from CDC by calling the Malaria Hotline at 770-488-7788 or by accessing CDC's Internet site at http://www.cdc.gov/travel. [ABSTRACT FROM AUTHOR]
- Published
- 2002
19. Heat-related deaths -- four states, July-August 2001, and United States, 1979-1999.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
20. Youth risk behavior surveillance -- United States, 2001.
- Author
-
Grunbaum JA, Kann L, Kinchen SA, Williams B, Ross JG, Lowry R, Kolke L, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: Priority health-risk behaviors, which contribute to the leading causes of mortality and morbidity among youth and adults, often are established during youth, extend into adulthood, are interrelated, and are preventable.Reporting Period Covered: This report covers data during February--December 2001.Description of System: The Youth Risk Behavior Surveillance System (YRBSS) monitors six categories of priority health-risk behaviors among youth and young adults; these behaviors contribute to unintentional injuries and violence; tobacco use; alcohol and other drug use; sexual behaviors that contribute to unintended pregnancy and sexually transmitted diseases (STDs), including human immunodeficiency virus (HIV) infection; unhealthy dietary behaviors; and physical inactivity. The YRBSS includes a national school-based survey conducted by CDC as well as state, territorial, and local school-based surveys conducted by education and health agencies. This report summarizes results from the national survey, 34 state surveys, and 18 local surveys conducted among students in grades 9--12 during February--December 2001.Results: In the United States, approximately three fourths of all deaths among persons aged 10--24 years result from only four causes: motor-vehicle crashes, other unintentional injuries, homicide, and suicide. Results from the 2001 national Youth Risk Behavior Survey demonstrated that numerous high school students engage in behaviors that increase their likelihood of death from these four causes: 14.1% had rarely or never worn a seat belt during the 30 days preceding the survey; 30.7% had ridden with a driver who had been drinking alcohol; 17.4% had carried a weapon during the 30 days preceding the survey; 47.1% had drunk alcohol during the 30 days preceding the survey; 23.9% had used marijuana during the 30 days preceding the survey; and 8.8% had attempted suicide during the 12 months preceding the survey. Substantial morbidity and social problems among young persons also result from unintended pregnancies and STDs, including HIV infection. In 2001, 45.6% of high school students had ever had sexual intercourse; 42.1% of sexually active students had not used a condom at last sexual intercourse; and 2.3% had ever injected an illegal drug. Two thirds of all deaths among persons aged >/=25 years result from only two causes: cardiovascular disease and cancer. The majority of risk behaviors associated with these two causes of death are initiated during adolescence. In 2001, 28.5% of high school students had smoked cigarettes during the 30 days preceding the survey; 78.6% had not eaten >/=5 servings per day of fruits and vegetables during the 7 days preceding the survey; 10.5% were overweight; and 67.8% did not attend physical education class daily.Public Health Actions: Health and education officials at national, state, and local levels are using these YRBSS data to analyze and improve policies and programs to reduce priority health-risk behaviors among youth. The YRBSS data also are being used to measure progress toward achieving 16 national health objectives for 2010 and 3 of the 10 leading health indicators. [ABSTRACT FROM AUTHOR]
- Published
- 2002
21. Outbreak of multidrug-resistant Salmonella Newport -- United States, January-April 2002.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
22. Hepatitis B vaccination -- United States, 1982-2002.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
23. Progress toward poliomyelitis eradication -- Pakistan and Afghanistan, January 2000-April 2002.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
24. West Nile virus activity -- United States, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
25. Update: influenza activity -- United States and worldwide, 2001-02 season, and composition of the 2002-03 influenza vaccine.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
26. Abortion surveillance -- United States, 1998.
- Author
-
Herndon J, Strauss LT, Whitehead S, Parker WY, Bartlett L, Zane S, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: In 1969, CDC began abortion surveillance to document the number and characteristics of women obtaining legal induced abortions, to monitor unintended pregnancy, and to assist efforts to identify and reduce preventable causes of morbidity and mortality associated with abortions.Reporting Period Covered: This report summarizes and reviews information reported to CDC regarding legal induced abortions obtained in the United States in 1998.Description of System: For each year since 1969, CDC has compiled abortion data by occurrence. From 1973 to 1997, data were received from or estimated for 52 reporting areas in the United States: 50 states, the District of Columbia, and New York City. In 1998, CDC compiled abortion data from only 48 reporting areas; Alaska, California, New Hampshire, and Oklahoma did not report.Results: In 1998, 884,273 legal induced abortions were reported to CDC, representing a 2% decrease from the 900,171 legal induced abortions reported by the same 48 reporting areas for 1997. The abortion ratio, defined as the number of abortions per 1,000 live births, was 264, compared with 274 in 1997 (for the same 48 areas); the abortion rate for these 48 areas was 17 per 1,000 women aged 15--44 years for both 1997 and 1998.The availability of information about characteristics of women who obtained an abortion in 1998 varied by state and by the number of states reporting each characteristic. The total number of legal induced abortions by state is reported by state of residence and state of occurrence; characteristics of women obtaining abortions in 1998 are reported by state of occurrence.Women undergoing an abortion were likely to be young (i.e., age <25 years), white, and unmarried; slightly more than one half were obtaining an abortion for the first time. Of all abortions for which gestational age was reported, 56% were performed at = weeks of gestation, and 88% were performed before 13 weeks. Overall, 19% of abortions were performed at the earliest weeks of gestation (=6 weeks), 18% at 7 weeks, and 19% at 8 weeks. From 1992 (when this information was first collected) through 1998, an increasing percentage of abortions were performed at the very early weeks of gestation. Few abortions were provided after 15 weeks of gestation; 4% were obtained at 16--20 weeks, and 1.4% were obtained at >/=21 weeks. A total of 24 reporting areas submitted information stating that they performed medical (nonsurgical) procedures (two of these areas categorized medical abortions with 'other' procedures), making up <1% of all procedures reported from all states.From 1993 through 1997 (years for which data have not been published previously and the most recent years for which such data are available), 36 women died as a result of complications from known legal induced abortion, and three deaths were associated with known illegal abortion. The annual case-fatality rate of legal induced abortion ranged from 0.3 to 0.8 abortion-related deaths per 100,000 reported legal induced abortions.Interpretation: From 1990 through 1995, the number of abortions declined each year; in 1996, the number increased slightly, but in 1997, it declined to its lowest level since 1978. In 1998, the number of abortions continued to decrease when comparing the 48 reporting areas. In 1997, as in previous years, deaths related to legal induced abortions occurred rarely.Public Health Actions Taken: The number and characteristics of women who obtain abortions in the United States should continue to be monitored so that trends in induced abortion can be assessed and efforts to prevent unintended pregnancy can be evaluated. [ABSTRACT FROM AUTHOR]
- Published
- 2002
27. State-specific trends in self-reported blood pressure screening and high blood pressure -- United States, 1991-1999.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
28. Nonfatal physical assault-related injuries treated in hospital emergency departments -- United States, 2000.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
29. Occupational exposures to air contaminants at the World Trade Center disaster site -- New York, September-October, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
30. State-specific mortality from stroke and distribution of place of death -- United States, 1999.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
31. Trends in cigarette smoking among high school students -- United States, 1991-2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
32. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: recommendations of the Panel on Clinical Practices for Treatment of HIV.
- Author
-
Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
The availability of an increasing number of antiretroviral agents and the rapid evolution of new information has introduced substantial complexity into treatment regimens for persons infected with human immunodeficiency virus (HIV). In 1996, the Department of Health and Human Services and the Henry J. Kaiser Family Foundation convened the Panel on Clinical Practices for the Treatment of HIV to develop guidelines for clinical management of HIV-Infected adults and adolescents (CDC. Report of the NIH Panel To Define Principles of Therapy of HIV Infection and Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998;47[RR-5]:1-41). This report, which updates the 1998 guidelines, addresses 1) using testing for plasma HIV ribonucleic acid levels (i.e., viral load) and CD4+ T cell count; 2) using testing for antiretroviral drug resistance; 3) considerations for when to initiate therapy; 4) adherence to antiretroviral therapy; 5) considerations for therapy among patients with advanced disease; 6) therapy-related adverse events; 7) interruption of therapy; 8) considerations for changing therapy and available therapeutic options; 9) treatment for acute HIV infection; 10) considerations for antiretroviral therapy among adolescents; 11) considerations for antiretroviral therapy among pregnant women; and 12) concerns related to transmission of HIV to others.Antiretroviral regimens are complex, have serious side effects, pose difficulty with adherence, and carry serious potential consequences from the development of viral resistance because of nonadherence to the drug regimen or suboptimal levels of antiretroviral agents. Patient education and involvement in therapeutic decisions is critical. Treatment should usually be offered to all patients with symptoms ascribed to HIV infection. Recommendations for offering antiretroviral therapy among asymptomatic patients require analysis of real and potential risks and benefits. Treatment should be offered to persons who have <350 CD4+ T cells/mm3 or plasma HIV ribonucleic acid (RNA) levels of >55,000 copies/mL (by b-deoxyribonucleic acid [bDNA] or reverse transcriptase-polymerase chain reaction [RT-PCR] assays). The recommendation to treat asymptomatic patients should be based on the willingness and readiness of the person to begin therapy; the degree of existing immunodeficiency as determined by the CD4+ T cell count; the risk for disease progression as determined by the CD4+ T cell count and level of plasma HIV RNA; the potential benefits and risks of initiating therapy in an asymptomatic person; and the likelihood, after counseling and education, of adherence to the prescribed treatment regimen.Treatment goals should be maximal and durable suppression of viral load, restoration and preservation of immunologic function, improvement of quality of life, and reduction of HIV-related morbidity and mortality. Results of therapy are evaluated through plasma HIV RNA levels, which are expected to indicate a 1.0 log10 decrease at 2-8 weeks and no detectable virus (<50 copies/mL) at 4-6 months after treatment initiation. Failure of therapy at 4-6 months might be ascribed to nonadherence, inadequate potency of drugs or suboptimal levels of antiretroviral agents, viral resistance, and other factors that are poorly understood. Patients whose therapy fails in spite of a high level of adherence to the regimen should have their regimen changed; this change should be guided by a thorough drug treatment history and the results of drug-resistance testing. Because of limitations in the available alternative antiretroviral regimens that have documented efficacy, optimal changes in therapy might be difficult to achieve for patients in whom the preferred regimen has failed. These decisions are further confounded by problems with adherence, toxicity, and resistance. For certain patients, participating in a clinical trial with or without access to new drugs or using a regimen that might not achieve complete suppression of viral replication might be preferable. Because concepts regarding HIV management are evolving rapidly, readers should check regularly for additional information and updates at the HIV/AIDS Treatment Information Service website (http://www.hivatis.org). [ABSTRACT FROM AUTHOR]
- Published
- 2002
33. Sexually transmitted diseases treatment guidelines 2002.
- Author
-
Workowski KA, Levine WC, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
These guidelines for the treatment of patients who have sexually transmitted diseases (STDs) were developed by the Centers for Disease Control and Prevention (CDC) after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on September 26--28, 2000. The information in this report updates the 1998 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 1998;47[No. RR-1]). Included in these updated guidelines are new alternative regimens for scabies, bacterial vaginosis, early syphilis, and granuloma inguinale; an expanded section on the diagnosis of genital herpes (including type-specific serologic tests); new recommendations for treatment of recurrent genital herpes among persons infected with human immunodeficiency virus (HIV); a revised approach to the management of victims of sexual assault; expanded regimens for the treatment of urethral meatal warts; and inclusion of hepatitis C as a sexually transmitted infection. In addition, these guidelines emphasize education and counseling for persons infected with human papillomavirus, clarify the diagnostic evaluation of congenital syphilis, and present information regarding the emergence of quinolone-resistant Neisseria gonorrhoeae and implications for treatment. Recommendations also are provided for vaccine-preventable STDs, including hepatitis A and hepatitis B. [ABSTRACT FROM AUTHOR]
- Published
- 2002
34. Progressing toward tuberculosis elimination in low-incidence areas of the United States: recommendations of the Advisory Council for the Elimination of Tuberculosis [corrected] [published erratum appears in MMWR MORB MORTAL WKLY REP 2002 May 17;51(19):427].
- Author
-
Jereb JA and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
In 2000, 22 states had tuberculosis (TB) incidence rates less than or equal to the Advisory Council for the Elimination of Tuberculosis (ACET) year-2000 interim objective of 3.5 cases/100,000 population, which is defined as low incidence. These states reported 1,949 TB cases, 11.9% of the national total of 16,377 cases in 2000. Health departments in low-incidence states, and in low-incidence regions within states with higher rates, need distinctive strategies, based on their specific epidemiologic characteristics, for maintaining skills and resources for finding increasingly rare TB cases, containing outbreaks, and ending transmission. Capacity for all the essential components of a TB prevention and control program must be retained at local, state, and national levels; failure to do so increases the risk of a new TB resurgence. In low-incidence areas, especially important are an adequate public health infrastructure and creative integration of resources, some of which until now have not played a role in TB control. Operational research is needed for determining the most efficient control measures. Eventually, with continued success in eliminating TB, low incidence will be attainable in all states, and the nation will profit from the lessons learned in the current low-incidence states. [ABSTRACT FROM AUTHOR]
- Published
- 2002
35. Guidelines for school programs to prevent skin cancer.
- Author
-
Glanz K, Saraiya M, Wechsler H, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Skin cancer is the most common type of cancer in the United States. Since 1973, new cases of the most serious form of skin cancer, melanoma, have increased approximately 150%. During the same period, deaths from melanoma have increased approximately 44%. Approximately 65%-90% of melanomas are caused by ultraviolet (UV) radiation. More than one half of a person's lifetime UV exposure occurs during childhood and adolescence because of more opportunities and time for exposure. Exposure to UV radiation during childhood plays a role in the future development of skin cancer. Persons with a history of >/=1 blistering sunburns during childhood or adolescence are two times as likely to develop melanoma than those who did not have such exposures. Studies indicate that protection from UV exposure during childhood and adolescence reduces the risk for skin cancer. These studies support the need to protect young persons from the sun beginning at an early age. School staff can play a major role in protecting children and adolescents from UV exposure and the future development of skin cancer by instituting policies, environmental changes, and educational programs that can reduce skin cancer risks among young persons.This report reviews scientific literature regarding the rates, trends, causes, and prevention of skin cancer and presents guidelines for schools to implement a comprehensive approach to preventing skin cancer. Based on a review of research, theory, and current practice, these guidelines were developed by CDC in collaboration with specialists in dermatology, pediatrics, public health, and education; national, federal, state, and voluntary agencies; schools; and other organizations. Recommendations are included for schools to reduce skin cancer risks through policies; creation of physical, social, and organizational environments that facilitate protection from UV rays; education of young persons; professional development of staff; involvement of families; health services; and program evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2002
36. Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria -- Ohio, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
37. Prevalence of selected maternal behaviors and experiences, pregnancy risk assessment monitoring system (PRAMS), 1999.
- Author
-
Beck LF, Morrow B, Lipscomb LF, Johnson CH, Gaffield ME, Rogers M, Gilbert BC, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: Various maternal behaviors and experiences before, during, and after pregnancy (e.g., unintended pregnancy, late entry into prenatal care, cigarette smoking, not breast-feeding) are associated with adverse health outcomes for both the mother and the infant. Information regarding maternal behaviors and experiences is needed to monitor trends, to enhance the understanding of the relations between behaviors and health outcomes, to plan and evaluate programs, to direct policy decisions, and to monitor progress toward Healthy People 2000 and 2010 objectives.Reporting Period Covered: This report covers data from 1993 through 1999.Description of System: The Pregnancy Risk Assessment Monitoring System (PRAMS) is an ongoing, state- and population-based surveillance system designed to monitor selected self-reported maternal behaviors and experiences that occur before, during, and after pregnancy among women who deliver a live-born infant. PRAMS employs a mixed-mode data collection methodology; up to three self-administered surveys are mailed to a sample of mothers, and nonresponders are followed up with a telephone interview. Self-reported survey data are linked to selected birth certificate data and weighted for sample design, nonresponse, and noncoverage to create annual PRAMS analysis data sets. PRAMS generates statewide estimates of various perinatal health topics among women delivering a live infant. Data for 1999 from 17 states are examined. In addition, trend data are examined for 12 states that had at least 3 years of data during 1993--1999.Results: In 1999, the prevalence of unintended pregnancy resulting in a live birth ranged from 33.7% to 52% across the 17 states. During 1993--1999, only one state reported a decreasing trend in the prevalence of unintended pregnancy. Women aged <20 years, black women, women with less than or equal to a high school education, and women receiving Medicaid were more likely to report unintended pregnancy. The prevalence of late or no entry into prenatal care ranged from 16.1% to 29.9%. The prevalence of late or no entry into prenatal care significantly decreased over time in seven of the 12 states with trend data. In general, women aged <20 years, black women, women with less than a high school education, and women receiving Medicaid were more likely to report late or no entry into prenatal care. The prevalence of smoking during the last 3 months of pregnancy ranged from 6.2% to 27.2%, and the prevalence decreased in five states from 1993 to 1999. Overall, smoking during the last 3 months of pregnancy was associated with younger age (<25 years), non-Hispanic ethnicity, having less than or equal to a high . school education, receiving Medicaid, and delivering a low birthweight infant. The prevalence of physical abuse by a husband or partner during pregnancy ranged from 2.1% to 6.3%. No trends were observed for physical abuse from 1996 to 1999, the only years for which these data were available. Across the 17 states, only Medicaid status was consistently associated with experiencing physical abuse during pregnancy. The prevalence of breast-feeding initiation ranged from 48% to 89%. Ten of 12 states with trend data reported increases in the prevalence of breast-feeding initiation. Overall, women aged <20 years, women with less than or equal to a high school education, and women receiving Medicaid were less likely to breast-feed. The prevalence of breast-feeding duration for at least 4 weeks ranged from 34.9% to 78.1%. From 1993 to 1999, increases in levels of breast-feeding for at least 4 weeks were observed in eight states. Women aged <25 years, black women, women with less than or equal to a high school education, and women receiving Medicaid were generally less likely to breast-feed for at least 4 weeks. The prevalence of back sleep position for infants ranged from 35.1% to 74.6%. Increases in the use of the back sleep position were observed in all 12 states with trend data from 1996 to 1999. Black race and having less than or equal to a high school education were consistently associated with not using the back sleep position.Interpretation: For surveillance during 1993--1999, the majority or all states observed increases in breast-feeding initiation, breast-feeding for at least 4 weeks, and back sleep position. Approximately one half of the states observed decreases for late or no entry into prenatal care and smoking during the last 3 months of pregnancy. Little or no progress was observed in the prevalence of unintended pregnancy or physical abuse during pregnancy.With few exceptions, the 17 states failed to meet the Healthy People 2000 objectives for the seven reported behaviors in 1999. Certain demographic and socioeconomic characteristics of women were associated with an increased risk for several of the behaviors, including younger age, black race, less education, and receipt of Medicaid just before or during pregnancy.Public Health Action: State maternal and child health programs can use these population-based data for reporting on core and state-negotiated performance measures of the Title V Block Grant Measurement Performance System. The data, which are important in planning and evaluation programs, help identify whether target populations are receiving services and help identify barriers to or gaps in services. The data can be shared with policy makers to direct policy decisions that might affect the health of mothers and infants. In addition, these findings can be used to monitor progress toward Healthy People 2000 and Healthy People 2010 objectives. [ABSTRACT FROM AUTHOR]
- Published
- 2002
38. Preliminary FoodNet data on the incidence of foodborne illnesses -- selected sites, United States, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
39. Racial and ethnic disparities in infant mortality rates -- 60 largest U.S. cities, 1995-1998.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
40. Annual smoking-attributable mortality, years of potential life lost, and economic costs -- United States, 1995-1999.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
41. Enterobacter sakazakii infections associated with the use of powdered infant formula -- Tennessee, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
42. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)
- Author
-
Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
This report updates the 2001 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (MMWR 2001;50[No. RR-4]:1--44). The 2002 recommendations include new or updated information regarding 1) the timing of influenza vaccination by risk group; 2) influenza vaccine for children aged 6--23 months; 3) the 2002--2003 trivalent vaccine virus strains: A/Moscow/10/99 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Hong Kong/330/2001-like strains; and 4) availability of certain influenza vaccine doses with reduced thimerosal content. A link to this report and other information related to influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm. [ABSTRACT FROM AUTHOR]
- Published
- 2002
43. Update: influenza activity -- United States, 2001-02 season.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
44. Alcohol use among women of childbearing age -- United States, 1991-1999 [corrected] [published erratum appears in MMWR MORB MORTAL WKLY REP 2002 Apr 12;51(14):308].
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
45. Reporting of laboratory-confirmed chlamydial infection and gonorrhea by providers affiliated with three large managed care organizations -- United States, 1995-1999.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
46. Progress toward global eradication of poliomyelitis, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
47. Surveillance for asthma -- United States, 1980-1999.
- Author
-
Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: Asthma, a chronic disease occurring among both children and adults, has been the focus of clinical and public health interventions during recent years. In addition, CDC has outlined a strategy to improve the timeliness and geographic specificity of asthma surveillance as part of a comprehensive public health approach to asthma surveillance.Reporting Period Covered: This report presents national data regarding self-reported asthma prevalence, school and work days lost because of asthma, and asthma-associated activity limitations (1980-1996); asthma-associated outpatient visits, asthma-associated hospitalizations, and asthma-associated deaths (1980-1999); asthma-associated emergency department visits (1992-1999); and self-reported asthma episodes or attacks (1997-1999).Description of Systems: CDC's National Center for Health Statistics (NCHS) conducts the National Health Interview Survey annually, which includes questions regarding asthma and asthma-related activity limitations. NCHS collects physician office-visit data in the National Ambulatory Medical Care Survey, emergency department and hospital outpatient data in the National Hospital Ambulatory Medical Care Survey, hospitalization data in the National Hospital Discharge Survey, and death data in the Mortality Component of the National Vital Statistics System.Results: During 1980-1996, asthma prevalence increased. Annual rates of persons reporting asthma episodes or at-tacks, measured during 1997-1999, were lower than the previously reported asthma prevalence rates, whereas the rates of lifetime asthma, also measured during 1997-1999, were higher than the previously reported rates. Since 1980, the proportion of children and adults with asthma who report activity limitation has remained stable. Since 1995, the rate of outpatient visits and emergency department visits for asthma increased, whereas the rates of hospitalization and death decreased. Blacks continue to have higher rates of asthma emergency department visits, hospitalizations, and deaths than do whites.Interpretation: Since the previous report in 1998 (CDC. Surveillance for Asthma -- United States, 1960-1995. MMWR 1998;47[No. SS-1]:1-28), changes in asthma-associated morbidity and death have been limited. Asthma remains a critical clinical and public health problem. Although data in this report indicate certain early indications of success in current asthma intervention programs (e.g., limited decreases in asthma hospitalization and death rates), the continued presence of substantial racial disparities in these asthma endpoints highlights the need for continued surveillance and targeted interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2002
48. Malaria surveillance -- United States, 1999.
- Author
-
Newman RD, Barber AM, Roberts J, Holtz T, Steketee RW, Parise ME, and United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Abstract
Problem/Condition: Malaria is caused by four species of intraerythrocytic protozoa of the genus Plasmodium (i.e., P. falciparum, P. vivax, P. ovale, or P. malariae). Malaria is transmitted by the bite of an infective female Anopheles sp. mosquito. The majority of malaria infections in the United States occur in persons who have traveled to areas with ongoing transmission. In the United States, cases can occur through exposure to infected blood products, by congenital transmission, or locally through mosquitoborne transmission. Malaria surveillance is conducted to identify episodes of local transmission and to guide prevention recommendations for travelers.Period Covered: Cases with onset of illness during 1999.Description of System: Malaria cases confirmed by blood films are reported to local and state health departments by health-care providers or laboratory staff. Case investigations are conducted by local and state health departments, and reports are transmitted to CDC through the National Malaria Surveillance System (NMSS). Data from NMSS serve as the basis for this report.esults: CDC received reports of 1,540 cases of malaria with an onset of symptoms during 1999 among persons in the United States or one of its territories. This number represents an increase of 25.5% from the 1,227 cases reported for 1998. P. falciparum, P. vivax, P. malariae, and P. ovale were identified in 46.0%, 30.7%, 4.6%, and 3.6% of cases, respectively. More than one species was present in 12 patients (0.8% of total). The infecting species was unreported or undetermined in 223 (14.5%) cases. The number of reported malaria cases acquired in Africa increased 27.6% (n = 901), compared with 1998, and an increase of 2.9% (n = 246) occurred in cases acquired in Asia, compared with 1998. Cases from the Americas increased by 19.7% (n = 274) from 1998. Of 831 U.S. civilians who acquired malaria abroad, 159 (19.1%) reported that they had followed a chemoprophylactic drug regimen recommended by CDC for the area to which they had traveled. Three patients became infected in the United States, all through probable local mosquitoborne transmission. Five deaths were attributed to malaria, all caused by P. falciparum.Interpretation: The 25.5% increase in malaria cases in 1999, compared with 1998, resulted primarily from increases in cases acquired in Africa and the Americas. This increase is possibly related to a change in the system by which states report to CDC, but it could also have resulted from local changes in disease transmission, increased travel to these regions, improved reporting to state and local health departments, or a decreased use of effective antimalarial chemoprophylaxis. In the majority of reported cases, U.S. civilians who acquired infection abroad were not on an appropriate chemoprophylaxis regimen for the country where they acquired malaria.Public Health Actions: Additional information was obtained concerning the five fatal cases and the three infections acquired in the United States. The NMSS surveillance form was modified to gather more detailed information regarding compliance with prescribed chemoprophylaxis regimens. Persons traveling to a malarious area should take one of the recommended chemoprophylaxis regimens appropriate to the region of travel, and travelers should use personal protection measures to prevent mosquito bites. Any person who has been to a malarious area and who subsequently develops a fever or influenza-like symptoms should seek medical care immediately; investigation should include a blood-film test for malaria. Malaria infections can be fatal if not diagnosed and treated promptly. Recommendations concerning prevention of malaria can be obtained from CDC. [ABSTRACT FROM AUTHOR]
- Published
- 2002
49. Progress toward tuberculosis control -- India, 2001.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
50. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children -- United States, 1998-2000.
- Author
-
United States Department of Health and Human Services. Centers for Disease Control and Prevention
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.